(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:731745 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AHCY mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:731745 6480464 epigallocatechin gallate results in decreased expression of AHCY protein CTD PMID:31195006 (1->4)-beta-D-glucan multiple interactions ISO RGD:736014 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AHCY mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:736014 6480464 1, 2-Dimethylhydrazine results in decreased expression of AHCY mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:736014 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AHCY mRNA CTD PMID:22206623 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:736014 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:736014 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrabromodibenzodioxine increases expression ISO RGD:736014 6480464 2 more ... CTD PMID:27604104 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of AHCY mRNA CTD PMID:18465118 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of AHCY mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736014 6480464 Tetrachlorodibenzodioxin affects the expression of AHCY mRNA CTD PMID:21570461 , PMID:26377647 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2-hydroxypropanoic acid decreases expression ISO RGD:731745 6480464 Lactic Acid results in decreased expression of AHCY mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases expression ISO RGD:736014 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of AHCY mRNA CTD PMID:20188158 4,4'-diaminodiphenylmethane decreases expression ISO RGD:736014 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of AHCY mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:736014 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of AHCY mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:731745 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of AHCY protein CTD PMID:34186270 4-hydroxyphenyl retinamide increases expression ISO RGD:736014 6480464 Fenretinide results in increased expression of AHCY mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of AHCY mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of AHCY mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO RGD:731745 6480464 Aflatoxin B1 results in increased methylation of AHCY gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:731745 6480464 Tretinoin results in decreased expression of AHCY mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of AHCY mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:731745 6480464 aristolochic acid I results in increased expression of AHCY protein CTD PMID:33212167 arsane multiple interactions ISO RGD:731745 6480464 [Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine, Arsenic results in increased expression of and results in increased activity of AHCY protein CTD PMID:18487201 arsane increases expression ISO RGD:731745 6480464 Arsenic results in increased expression of AHCY mRNA CTD PMID:18487201 arsenic atom increases expression ISO RGD:731745 6480464 Arsenic results in increased expression of AHCY mRNA CTD PMID:18487201 arsenic atom multiple interactions ISO RGD:731745 6480464 [Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine, Arsenic results in increased expression of and results in increased activity of AHCY protein CTD PMID:18487201 arsenite(3-) multiple interactions ISO RGD:731745 6480464 arsenite promotes the reaction [G3BP1 protein binds to AHCY mRNA], arsenite promotes the reaction [G3BP1 protein binds to AHCY protein] CTD PMID:32406909 arsenous acid increases expression ISO RGD:731745 6480464 Arsenic Trioxide results in increased expression of AHCY mRNA CTD PMID:22521957 azoxystrobin increases expression ISO RGD:731745 6480464 azoxystrobin results in increased expression of AHCY mRNA CTD PMID:33512557 benzene increases expression ISO RGD:736014 6480464 Benzene results in increased expression of AHCY mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene increases methylation ISO RGD:731745 6480464 Benzo(a)pyrene results in increased methylation of AHCY promoter CTD PMID:27901495 benzo[b]fluoranthene decreases expression ISO RGD:736014 6480464 benzo(b)fluoranthene results in decreased expression of AHCY mRNA CTD PMID:26377693 benzoates decreases expression ISO RGD:731745 6480464 Benzoates analog results in decreased expression of AHCY mRNA CTD PMID:29472718 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AHCY mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A decreases expression ISO RGD:731745 6480464 bisphenol A results in decreased expression of AHCY protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:736014 6480464 bisphenol A results in decreased expression of AHCY mRNA, bisphenol A results in decreased expression of AHCY protein CTD PMID:30951980 , PMID:35999755 bisphenol A affects expression ISO RGD:731745 6480464 bisphenol A affects the expression of AHCY mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AHCY protein CTD PMID:22649256 bisphenol F decreases expression ISO RGD:736014 6480464 bisphenol F results in decreased expression of AHCY mRNA CTD PMID:30951980 buspirone increases expression EXP 6480464 Buspirone results in increased expression of AHCY mRNA CTD PMID:24136188 buta-1,3-diene decreases expression ISO RGD:736014 6480464 1, 3-butadiene results in decreased expression of AHCY mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO RGD:731745 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AHCY protein CTD PMID:33040242 cadmium dichloride multiple interactions ISO RGD:731745 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AHCY protein CTD PMID:33040242 cadmium dichloride increases expression ISO RGD:731745 6480464 Cadmium Chloride results in increased expression of AHCY protein CTD PMID:24527689 caffeine decreases expression ISO RGD:731745 6480464 Caffeine results in decreased expression of AHCY protein CTD PMID:31195006 carbon nanotube increases expression ISO RGD:736014 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 ceruletide decreases expression EXP 6480464 Ceruletide results in decreased expression of AHCY protein CTD PMID:18024178 chloropicrin decreases expression ISO RGD:731745 6480464 chloropicrin results in decreased expression of AHCY mRNA CTD PMID:26352163 , PMID:28476498 choline multiple interactions ISO RGD:736014 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of AHCY mRNA more ... CTD PMID:20938992 more ... choline multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of AHCY protein CTD PMID:19566968 cisplatin increases expression ISO RGD:731745 6480464 Cisplatin results in increased expression of AHCY mRNA, Cisplatin results in increased expression of AHCY protein CTD PMID:21424131 , PMID:27392435 cisplatin multiple interactions ISO RGD:731745 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of AHCY mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:736014 6480464 Clofibrate results in decreased expression of AHCY mRNA CTD PMID:17585979 copper atom decreases expression EXP 6480464 Copper results in decreased expression of AHCY mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of AHCY mRNA CTD PMID:22465980 CU-O LINKAGE decreases expression ISO RGD:731745 6480464 cupric oxide results in decreased expression of AHCY protein CTD PMID:25470785 D-penicillamine multiple interactions ISO RGD:736014 6480464 Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of AHCY protein] CTD PMID:22945834 D-penicillamine increases activity ISO RGD:736014 6480464 Penicillamine results in increased activity of AHCY protein CTD PMID:22945834 diarsenic trioxide increases expression ISO RGD:731745 6480464 Arsenic Trioxide results in increased expression of AHCY mRNA CTD PMID:22521957 doxorubicin decreases expression ISO RGD:731745 6480464 Doxorubicin results in decreased expression of AHCY mRNA CTD PMID:18510171 doxorubicin increases expression ISO RGD:731745 6480464 Doxorubicin results in increased expression of AHCY mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO RGD:731745 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AHCY protein CTD PMID:23301498 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of AHCY mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:736014 6480464 [1 more ... CTD PMID:20938992 more ... folic acid multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of AHCY protein CTD PMID:19566968 folic acid decreases expression ISO RGD:736014 6480464 Folic Acid deficiency results in decreased expression of AHCY mRNA, Folic Acid deficiency results in decreased expression of AHCY protein CTD PMID:25384423 folic acid increases expression ISO RGD:736014 6480464 Folic Acid results in increased expression of AHCY mRNA, Folic Acid results in increased expression of AHCY protein CTD PMID:30920123 formaldehyde decreases expression ISO RGD:731745 6480464 Formaldehyde results in decreased expression of AHCY mRNA CTD PMID:23649840 fumonisin B1 decreases expression ISO RGD:736014 6480464 fumonisin B1 results in decreased expression of AHCY mRNA CTD PMID:16221962 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of AHCY mRNA CTD PMID:24136188 glycine betaine decreases expression ISO RGD:736014 6480464 Betaine results in decreased expression of AHCY mRNA CTD PMID:22945834 glycine betaine decreases expression EXP 6480464 Betaine results in decreased expression of AHCY mRNA CTD PMID:26391144 homocysteine multiple interactions ISO RGD:731745 6480464 [Arsenic results in increased expression of and results in increased activity of AHCY protein] which results in increased chemical synthesis of Homocysteine CTD PMID:18487201 isoprenaline increases expression ISO RGD:736014 6480464 Isoproterenol results in increased expression of AHCY mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:731745 6480464 Ivermectin results in decreased expression of AHCY protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:736014 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in decreased expression of AHCY mRNA more ... CTD PMID:20938992 , PMID:29127188 L-methionine multiple interactions EXP 6480464 [Folic Acid deficiency co-treated with Methionine deficiency co-treated with Choline deficiency] results in increased expression of AHCY protein CTD PMID:19566968 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of AHCY mRNA CTD PMID:24136188 lipopolysaccharide multiple interactions ISO RGD:731745 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of AHCY mRNA CTD PMID:35877022 lovastatin decreases expression ISO RGD:736014 6480464 Lovastatin results in decreased expression of AHCY mRNA CTD PMID:20493250 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of AHCY protein CTD PMID:30467583 methidathion increases expression ISO RGD:736014 6480464 methidathion results in increased expression of AHCY mRNA CTD PMID:34813904 methotrexate affects expression ISO RGD:736014 6480464 Methotrexate affects the expression of AHCY mRNA CTD PMID:18502557 methylmercury chloride decreases expression ISO RGD:731745 6480464 methylmercuric chloride results in decreased expression of AHCY mRNA CTD PMID:23179753 , PMID:27188386 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:736014 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of AHCY mRNA CTD PMID:22401849 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of AHCY mRNA CTD PMID:20360939 N-nitrosodiethylamine multiple interactions ISO RGD:736014 6480464 [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of AHCY mRNA CTD PMID:29127188 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of AHCY protein CTD PMID:19716841 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of AHCY mRNA CTD PMID:33484710 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of AHCY protein CTD PMID:19260726 ozone multiple interactions ISO RGD:736014 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AHCY mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AHCY mRNA CTD PMID:34911549 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of AHCY mRNA, Acetaminophen affects the expression of AHCY protein CTD PMID:16687475 , PMID:19103213 paracetamol increases expression ISO RGD:731745 6480464 Acetaminophen results in increased expression of AHCY mRNA CTD PMID:22230336 parathion increases expression ISO RGD:736014 6480464 Parathion results in increased expression of AHCY mRNA CTD PMID:34813904 PCB138 multiple interactions ISO RGD:736014 6480464 [2 more ... CTD PMID:25510870 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorododecanoic acid decreases expression EXP 6480464 perfluorododecanoic acid results in decreased expression of AHCY protein CTD PMID:26168851 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:736014 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AHCY mRNA CTD PMID:36331819 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of AHCY mRNA CTD PMID:19162173 picoxystrobin increases expression ISO RGD:731745 6480464 picoxystrobin results in increased expression of AHCY mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:736014 6480464 pirinixic acid results in increased expression of AHCY protein CTD PMID:15226431 pirinixic acid decreases expression ISO RGD:736014 6480464 pirinixic acid results in decreased expression of AHCY mRNA CTD PMID:16221962 , PMID:23811191 pirinixic acid multiple interactions ISO RGD:736014 6480464 PPARA protein affects the reaction [pirinixic acid results in decreased expression of AHCY mRNA] CTD PMID:16221962 potassium chromate increases expression ISO RGD:731745 6480464 potassium chromate(VI) results in increased expression of AHCY mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:731745 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AHCY mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:736014 6480464 Pregnenolone Carbonitrile results in increased expression of AHCY mRNA CTD PMID:28903501 propiconazole increases metabolic processing ISO RGD:736014 6480464 propiconazole results in increased metabolism of AHCY protein CTD PMID:19714882 Propiverine affects binding EXP 6480464 propiverine binds to AHCY protein CTD PMID:29273565 pyrimidifen increases expression ISO RGD:731745 6480464 pyrimidifen results in increased expression of AHCY mRNA CTD PMID:33512557 rac-lactic acid decreases expression ISO RGD:731745 6480464 Lactic Acid results in decreased expression of AHCY mRNA CTD PMID:30851411 resveratrol affects expression ISO RGD:731745 6480464 resveratrol affects the expression of AHCY protein CTD PMID:22234583 rotenone increases expression ISO RGD:731745 6480464 Rotenone results in increased expression of AHCY mRNA CTD PMID:33512557 S-adenosyl-L-homocysteine increases hydrolysis ISO RGD:731745 6480464 AHCY results in increased hydrolysis of S-Adenosylhomocysteine CTD PMID:26974671 sarin decreases expression ISO RGD:731745 6480464 Sarin results in decreased expression of AHCY mRNA CTD PMID:19522546 sodium arsenite affects methylation ISO RGD:731745 6480464 sodium arsenite affects the methylation of AHCY gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:731745 6480464 sodium arsenite results in increased expression of AHCY protein CTD PMID:29207610 streptozocin multiple interactions ISO RGD:736014 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of AHCY mRNA, [Streptozocin co-treated with Dietary Fats] results in increased methylation of AHCY gene CTD PMID:29127188 T-2 toxin increases expression ISO RGD:731745 6480464 T-2 Toxin results in increased expression of AHCY protein CTD PMID:34581912 tetrachloromethane multiple interactions ISO RGD:736014 6480464 [Diethylnitrosamine co-treated with Carbon Tetrachloride] results in decreased expression of AHCY mRNA CTD PMID:29127188 tetrahydrocurcumin affects expression ISO RGD:736014 41410880 Tetrahydrocurcumin affects expression of protein and mRNA in ischemia/reperfusion CBS+/- mice RGD thimerosal decreases expression ISO RGD:731745 6480464 Thimerosal results in decreased expression of AHCY mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of AHCY mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:736014 6480464 titanium dioxide results in increased expression of AHCY mRNA CTD PMID:29264374 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of AHCY mRNA CTD PMID:19448997 trimellitic anhydride increases expression ISO RGD:736014 6480464 trimellitic anhydride results in increased expression of AHCY mRNA CTD PMID:19042947 Triptolide decreases expression ISO RGD:736014 6480464 triptolide results in decreased expression of AHCY mRNA CTD PMID:32835833 tungsten increases expression ISO RGD:736014 6480464 Tungsten results in increased expression of AHCY mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:736014 6480464 Valproic Acid affects the expression of AHCY mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:731745 6480464 Valproic Acid results in decreased expression of AHCY mRNA CTD PMID:23179753 , PMID:27188386 vancomycin increases expression ISO RGD:736014 6480464 Vancomycin results in increased expression of AHCY mRNA CTD PMID:18930951 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of AHCY gene CTD PMID:31079544 warfarin decreases expression ISO RGD:736014 6480464 Warfarin results in decreased expression of AHCY mRNA CTD PMID:20493250